217 related articles for article (PubMed ID: 24587329)
1. Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
Gao Y; Yu X; Xue B; Zhou F; Wang X; Yang D; Liu N; Xu L; Fang X; Zhu H
PLoS One; 2014; 9(2):e90333. PubMed ID: 24587329
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
Yu X; Gao Y; Xue B; Wang X; Yang D; Qin Y; Yu R; Liu N; Xu L; Fang X; Zhu H
Antiviral Res; 2014 Jun; 106():116-24. PubMed ID: 24713119
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein.
Yang D; Meng X; Yu Q; Xu L; Long Y; Liu B; Fang X; Zhu H
Antimicrob Agents Chemother; 2013 Oct; 57(10):4937-44. PubMed ID: 23877701
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatitis C virus production by aptamers against the core protein.
Shi S; Yu X; Gao Y; Xue B; Wu X; Wang X; Yang D; Zhu H
J Virol; 2014 Feb; 88(4):1990-9. PubMed ID: 24307579
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation of Hepatitis C Virus NS2 Regulates Its Subcellular Localization and NS2-NS3 Autocleavage.
Wu MJ; Shanmugam S; Welsch C; Yi M
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597774
[TBL] [Abstract][Full Text] [Related]
7. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation.
Madan V; Paul D; Lohmann V; Bartenschlager R
Gastroenterology; 2014 May; 146(5):1361-72.e1-9. PubMed ID: 24486951
[TBL] [Abstract][Full Text] [Related]
9. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication.
Friborg J; Levine S; Chen C; Sheaffer AK; Chaniewski S; Voss S; Lemm JA; McPhee F
Antimicrob Agents Chemother; 2013 Mar; 57(3):1312-22. PubMed ID: 23274666
[TBL] [Abstract][Full Text] [Related]
10. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
12. Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent.
Kwon HJ; Xing W; Chan K; Niedziela-Majka A; Brendza KM; Kirschberg T; Kato D; Link JO; Cheng G; Liu X; Sakowicz R
PLoS One; 2015; 10(4):e0122844. PubMed ID: 25856426
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation.
Guo M; Pei R; Yang Q; Cao H; Wang Y; Wu C; Chen J; Zhou Y; Hu X; Lu M; Chen X
J Virol; 2015 Feb; 89(4):2367-77. PubMed ID: 25505071
[TBL] [Abstract][Full Text] [Related]
14. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
15. Epoxide based inhibitors of the hepatitis C virus non-structural 2 autoprotease.
Shaw J; Fishwick CW; Harris M
Antiviral Res; 2015 May; 117():20-6. PubMed ID: 25703928
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
17. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.
Chen WC; Wang SY; Chiu CC; Tseng CK; Lin CK; Wang HC; Lee JC
Antimicrob Agents Chemother; 2013 Mar; 57(3):1180-91. PubMed ID: 23254429
[TBL] [Abstract][Full Text] [Related]
18. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.
Galli A; Scheel TKH; Prentoe JC; Mikkelsen LS; Gottwein JM; Bukh J
J Gen Virol; 2013 Oct; 94(Pt 10):2221-2235. PubMed ID: 23907394
[TBL] [Abstract][Full Text] [Related]
20. RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.
Marton S; Romero-López C; Berzal-Herranz A
J Viral Hepat; 2013 Feb; 20(2):103-12. PubMed ID: 23301545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
